Digestive bleeding and heart failure as a presentation of multiple myeloma

Authors

  • María Cortés Avilés-Martínez Internal Medicine Service, Hospital General de Albacete, Albacete, Spain https://orcid.org/0000-0002-5094-7871
  • Amparo Puerta-García Internal Medicine Service, Hospital Quirónsalud Albacete, Albacete, Spain
  • Gloria Giraldo-Alfaro Servicio de Radiodiagnóstico, Hospital General de Albacete, Albacete, Spain
  • Lorenzo Algarra-Algarra Servicio de Hematología, Hospital General de Albacete, Albacete, Spain
  • Manuel Vives-Soto Internal Medicine Service, Hospital Quirónsalud Albacete, Albacete, Spain

DOI:

https://doi.org/10.32818/reccmi.a8n3a9

Keywords:

multiple myeloma , immunoglobulin light-chain amyloidosis, heart failure, gastrointestinal hemorrhage

Abstract

AL cardiac amyloidosis is caused by extracellular deposition of immunoglobulin light chains in the heart. It is a multisystemic disease that can affect multiple organs, and around 10% of the cases are associated with multiple myeloma. The presence of AL amyloidosis is an independent factor of poor prognosis, not only for symptomatic multiple myeloma but also for latent multiple myeloma. We present below an unusual case of IgA-lambda multiple myeloma that manifested with recurrent gastrointestinal bleeding and heart failure.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Vaxman I, Gertz M. When to suspect a diagnosis of amyloidosis. Acta Haematol. 2020; 143(4): 304-311. doi: https://doi.org/10.1159/000506617 (último acceso nov. 2023).

Siau K, Elzubeir A, Cooper SC, Iqbal T. Amyloidosis: an unusual cause of upper gastrointestinal bleeding. BMJ Case Reports. 2016: bcr2016217653. doi: http://dx.doi.org/10.1136/bcr-2016-217653 (último acceso nov. 2023).

Xu J, Wang M, Shen Y, Yan M, Xie W, Wang B, et al. Effects of amyloid light-chain amyloidosis on clinical characteristics and prognosis in multiple myeloma: a single-center retrospective study. Cancer Manag Res. 2021; 13: 1343–1356. doi: https://doi.org/10.2147/CMAR.S287922 (último acceso nov. 2023)

Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, et al. ACC expert consensus decision pathway on cardiac amyloidosis. J Am Coll Cardiol. 2023; 81: 1076-1126. doi: https://doi.org/10.1016/j.jacc.2022.11.022 (último acceso nov. 2023).

Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023; 44:3503-3626. doi: https://doi.org/10.1093/eurheartj/ehad194 (último acceso nov. 2023).

Fulton N, Rajiah P. Utility of magnetic resonance imaging in the evaluation of left ventricular thickening. Insights Imaging. 2017; 8: 279-293. doi: https://doi.org/10.1007/s13244-017-0549-2 (último acceso nov. 2023).

Kirichenko Y, Ilgisonis IS, Nakhodnova ES, Sokolova IY, Bochkarnikova OV, Kardanova SA, et al. Case report: AL amyloidosis severe restrictive cardiomyopathy associated with multiple myeloma - diagnostic difficulties. Front Cardiovasc Med. 2022; 9: 862409. doi: https://doi.org/10.3389/fcvm.2022.862409

Published

2023-12-31

How to Cite

1.
Avilés-Martínez MC, Puerta-García A, Giraldo-Alfaro G, Algarra-Algarra L, Vives-Soto M. Digestive bleeding and heart failure as a presentation of multiple myeloma. Rev Esp Casos Clin Med Intern [Internet]. 2023 Dec. 31 [cited 2024 Nov. 23];8(3):135-8. Available from: https://www.reccmi.com/RECCMI/article/view/919

Most read articles by the same author(s)